Pfizer Comprehensive Income 2010-2024 | PFE

Pfizer comprehensive income for the quarter ending September 30, 2024 was $-7.816B, a 3.53% decline year-over-year.

  • Pfizer comprehensive income for 2023 was $-7.961B, a 4.13% decline from 2022.
  • Pfizer comprehensive income for 2022 was $-8.304B, a 40.82% increase from 2021.
  • Pfizer comprehensive income for 2021 was $-5.897B, a 11.05% increase from 2020.

Pfizer Comprehensive Income 2010-2024 | PFE

  • Pfizer comprehensive income for 2023 was $-7.961B, a 4.13% decline from 2022.
  • Pfizer comprehensive income for 2022 was $-8.304B, a 40.82% increase from 2021.
  • Pfizer comprehensive income for 2021 was $-5.897B, a 11.05% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$789.4B
Novo Nordisk (NVO)$481.1B
Johnson & Johnson (JNJ)$374.3B
AbbVie (ABBV)$352.5B
Merck (MRK)$260.4B
Novartis AG (NVS)$217.6B
AstraZeneca (AZN)$200B
Sanofi (SNY)$130.2B
Innoviva (INVA)$1.3B